NCT00827515View on ClinicalTrials.gov

Relative Bioavailability and Food Effect Study

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 28, 2009

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2009

Conditions
Pain
Interventions
DRUG

PH797804

Single oral dose of 5mg PH797804 as a powder in capsule formulation in the fasted state

DRUG

PH797804

Single oral dose of 5mg PH797804 as a powder in capsule formulation in the fed state

DRUG

PH797804

Single oral dose of 5mg PH797804 as an immediate release tablet formulation in the fasted state

DRUG

PH797804

Single oral dose of 5mg PH797804 as an immediate release tablet formulation in the fed state

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00827515 - Relative Bioavailability and Food Effect Study | Biotech Hunter | Biotech Hunter